首页/数据集/Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer

Name: Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer
Creator: University of Alabama at Birmingham
Published: 2024-11-23T00:14:09+08:00

integrated proteome resources2026-02-07 收录

胰腺癌治疗

药物联合疗法

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0010315000 数据链接链接失效反馈

官方服务：

资源简介：

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer

应用场景：

提供机构：

University of Alabama at Birmingham

创建时间：

2024-11-23

胰腺癌治疗

生存分析

Introduction Pegylated liposomal irinotecan (nal-IRI) in combination with fluorouracil (5-FU) and leucovorin (LV) has achieved a median overall survival of 6.1 months in patients with metastatic pancr

DataCite Commons2025-06-04 更新70

Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal Cancer

结直肠癌治疗

药物联合疗法

Limited agents are optional after standard first and second line treatment for mCRC. Only Regorafenib and Fruquintinib are approved in China. PFS of these targeted drugs are not very long. Pemetrexed

NIAID Data Ecosystem50

Table_4_S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study.docx

胰腺癌治疗

药物疗效

BackgroundIn our previous phase II study, nab-paclitaxel plus S-1 (NPS) showed encouraging objective response rate (ORR) as first-line treatment for advanced pancreatic adenocarcinoma (APAC). This stu

NIAID Data Ecosystem40

Next generation sequencing facilitates quantitative analysis of STRAP-dependent alternative splicing events

下一代测序技术

替代剪接

We report the application of next generation sequencing for evaluating alternative splicing (AS) events on lineage-committed WT and Strap-KO embryoid body (EB) cells. We also analyzed AS during mouse

干细胞与再生医学数据中心2022-02-20 更新50

Radiosensitizing pancreatic cancer with PARP inhibitor and gemcitabine: an in vivo and a whole-transcriptome analysis after proton or photon irradiation

胰腺癌治疗

转录组分析

RNA sequencing profiling showed differentially expressed genes implicated in categories such as DNA repair, type I interferon signaling and cell cycle. Moreover, a large amount of lncRNA were dysregul

干细胞与再生医学数据中心2022-02-20 更新40

Paricalcitol and hydroxychloroquine modulates extracellular matrix and enhance chemotherapy efficacy in pancreatic cancer

资源简介：

相关数据集